Individuals taking cross-sex hormones to relieve their gender dysphoria have “a substantially increased risk of serious cardiac events, including stroke, heart attack, and pulmonary embolism,” according to a new American College of Cardiology (ACC) study.
As the transgenderism phenomenon has exploded, doctors have been prescribing hormone therapy for patients who claim to have a “gender identity” that differs from the sex embedded in their genes. An ACC press release describing the study notes that “recent data suggest about 1 million to 1.6 million people identify as transgender in the U.S. and that hormone therapy use is rising rapidly, especially among teens and young adults.” A Komodo Health Inc. study found that the number of American children diagnosed with gender dysphoria tripled between 2017 and 2021, during which time over 14,000 kids were given cross-sex hormones.